INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,508,000 | +26.8% | 4,653,772 | +6.0% | 0.15% | +39.6% |
| Q2 2023 | $92,652,000 | +34.1% | 4,391,080 | +8.4% | 0.11% | +29.3% |
| Q1 2023 | $69,093,000 | -5.3% | 4,052,364 | +11.0% | 0.08% | -4.7% |
| Q4 2022 | $72,943,000 | -4.9% | 3,650,805 | +2.6% | 0.09% | -8.5% |
| Q3 2022 | $76,665,000 | +11.1% | 3,557,924 | +1.7% | 0.09% | +22.1% |
| Q2 2022 | $69,000,000 | -13.0% | 3,499,010 | +3.7% | 0.08% | +28.3% |
| Q1 2022 | $79,315,000 | -8.4% | 3,375,105 | +6.1% | 0.06% | -16.7% |
| Q4 2021 | $86,620,000 | -6.8% | 3,179,883 | -5.8% | 0.07% | -8.9% |
| Q3 2021 | $92,954,000 | +2.4% | 3,375,266 | +5.8% | 0.08% | +5.3% |
| Q2 2021 | $90,777,000 | +914.9% | 3,189,635 | +1114.6% | 0.08% | +476.9% |
| Q1 2021 | $8,944,000 | +5745.8% | 262,617 | +5625.2% | 0.01% | – |
| Q4 2020 | $153,000 | +4.1% | 4,587 | 0.0% | 0.00% | – |
| Q3 2020 | $147,000 | +16.7% | 4,587 | 0.0% | 0.00% | – |
| Q2 2020 | $126,000 | -92.4% | 4,587 | -93.4% | 0.00% | -100.0% |
| Q2 2018 | $1,656,000 | – | 70,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |